A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
Theranostics · 2023
DOI: 10.7150/thno.83486 ↗Kurz gefasst
Editorial in der Zeitschrift Theranostics, 2023. Verfasst von Uttam K Sinha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA. Hauptthemen laut MEDLINE: Transcription Factors, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA.
- Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Sinha, U. K., & Lin, D. C. (2023). A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy. Theranostics. https://doi.org/10.7150/thno.83486
Vancouver
Sinha UK, Lin DC. A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy. Theranostics. 2023. doi:10.7150/thno.83486
BibTeX
@article{Sinha2023,
author = {Sinha, Uttam K and Lin, De-Chen},
title = {A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.83486}
}
EUVIMED